No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3888 |
4. Check minimum number of eventsNone |
3888 |
5. Include endpointsNone |
3888 |
6. Filter based on genotype QC (FinnGen only) |
3888 |
Control definitions (FinnGen only)
- Control exclude
- L12_OTHERSKINSUBCUTIS
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L90
- Name in latin
- Lichen sclerosus et atrophicus
Similar endpoints
↥List of similar endpoints to
Lichen sclerosus et atrophicus
based on the number of shared cases.
Similar with more cases:
- Atrophic disorders of skin
- Other disorders of skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 21817 | 18224 | 3552 |
| Only index persons | 21007 | 17541 | 3466 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.45 | 0.52 | 0.10 |
| Only index persons | 0.56 | 0.64 | 0.13 |
| Median age at first event (years) | |||
| Whole population | 60.38 | 64.39 | 39.87 |
| Only index persons | 60.31 | 64.36 | 39.85 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3888 | 3385 | 503 |
| Unadjusted period prevalence (%) | 1.03 | 1.15 | 0.22 |
| Median age at first event (years) | 62.64 | 64.07 | 53.01 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3361
- Matched controls
- 33608
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
62.9
323.0
1208
297
ULA02
NOMESCO Finland
Kolposcopy
12.0
323.0
1347
1770
D07AD01
ATC
clobetasol; topical
21.7
323.0
2324
3147
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
16384.0
323.0
3335
134
D07AC01
ATC
betamethasone; topical
3.3
223.7
1676
7740
E0000UV
ATC
NA
2.8
173.8
1764
9440
D07AB02
ATC
hydrocortisone butyrate; topical
3.0
170.2
1376
6339
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
3.8
162.2
821
2657
N90.4
ICD-10 Finland
Leukoplakia of vulva
39.3
135.1
172
46
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.4
112.7
1321
7096
KGH10
NOMESCO Finland
Operation for phimosis
17.7
106.3
170
101
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.5
103.4
1032
5040
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
13.0
90.5
164
132
L29.2
ICD-10 Finland
Pruritus vulvae
9.3
82.7
178
201
J02AC01
ATC
fluconazole; systemic
2.0
74.9
1700
11529
D07AC13
ATC
mometasone; topical
2.1
73.4
1117
6450
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.2
70.0
403
1364
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.9
68.4
2245
17166
E000006
ATC
NA
3.2
67.3
396
1360
LEB00
NOMESCO Finland
Biopsy of vagina
6.5
64.9
176
283
N76.3
ICD-10 Finland
Subacute and chronic vulvitis
11.2
61.5
119
110
N76.6
ICD-10 Finland
Ulceration of vulva
12.8
59.2
107
86
L94.0
ICD-10 Finland
Localized scleroderma [morphea]
196.6
56.2
58
*
N48.1
ICD-10 Finland
Balanoposthitis
12.5
54.8
100
82
LFC00
NOMESCO Finland
Partial excision of vulva
27.6
53.1
73
27
N90.8
ICD-10 Finland
Other specified noninflammatory disorders of vulva and perineum
11.0
53.1
103
96
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.5
52.6
480
2137
L43.9
ICD-10 Finland
Lichen planus, unspecified
6.0
52.4
150
259
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
10.6
51.0
101
98
N90.9
ICD-10 Finland
Noninflammatory disorder of vulva and perineum, unspecified
13.4
50.9
90
69
N90.0
ICD-10 Finland
Mild vulvar dysplasia
19.9
48.8
74
38
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.1
47.9
652
3488
E000001
ATC
NA
2.0
47.7
746
4221
L43.8
ICD-10 Finland
Other lichen planus
5.7
46.9
139
251
D07AB01
ATC
clobetasone; topical
3.8
43.8
193
524
X16
ICPC
Vulval symptom/complaint
6.9
42.5
109
163
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
26.1
38.9
54
21
D07CA01
ATC
hydrocortisone and antibiotics; topical
2.1
38.3
500
2608
L90.9
ICD-10 Finland
Atrophic disorder of skin, unspecified
+∞
35.5
34
*
7010B
ICD-9 Finland
Other hypertrophic and atrophic conditions of skin, Circumscribed scleroderma[LICHEN SCLEROSUS ET ATROPHICUS]
+∞
33.4
32
*
D05BB02
ATC
acitretin; oral
4.5
31.7
116
266
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.1
31.6
409
2111
C51.01
ICD-10 Finland
Squamous cell carcinoma of the labium majus
27.6
30.2
41
15
UJF32
NOMESCO Finland
Coloscopy
1.6
28.0
865
5925
8070/3-C51.9
ICD-O-3
Squamous cell carcinoma, NOS, of vulva, NOS
33.1
27.8
36
11
D07BC01
ATC
betamethasone and antiseptics; topical
2.0
27.7
399
2144
LCA06
NOMESCO Finland
Biopsy of endometrium
1.8
26.8
520
3104
UKC02
NOMESCO Finland
Cystoscopy
1.9
25.9
410
2278
G04BD12
ATC
mirabegron; oral
1.9
25.0
382
2094
G01AA10
ATC
clindamycin; vaginal
1.7
24.6
598
3815
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
13.7
24.5
42
31
C51.11
ICD-10 Finland
Squamous cell carcinoma of the labium minus
28.4
23.1
31
11
N77.8*L43.9
ICD-10 Finland
Vulvovaginal ulceration and inflammation caused by lichen ruber planus
17.3
23.1
36
21
KGB00
NOMESCO Finland
Biopsy of penis
84.0
22.7
25
*
D07AB08
ATC
desonide; topical
1.9
22.4
331
1791
J01DB01
ATC
cefalexin; oral
1.5
22.2
2614
23467
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
2.3
22.0
221
1019
N39.3
ICD-10 Finland
Stress incontinence
1.9
22.0
336
1843
N48.0
ICD-10 Finland
Leukoplakia of penis
110.7
20.6
22
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
20.2
904
6663
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
4.1
20.1
80
201
N90.1
ICD-10 Finland
Moderate vulvar dysplasia
16.1
20.1
32
20
G03CA04
ATC
estriol; systemic, vaginal
1.8
20.1
365
2123
N48.6
ICD-10 Finland
Induratio penis plastica
27.2
20.0
27
10
L43
ICD-10 Finland
Lichen planus
4.8
19.7
66
140
D07AA02
ATC
hydrocortisone; topical
1.7
19.6
416
2540
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
19.4
2184
19100
J01EA01
ATC
trimethoprim; systemic
1.5
19.3
942
7059
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
18.9
848
6240
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
7.2
18.7
45
63
L80
ICD-10 Finland
Vitiligo
18.1
17.8
27
15
H03AA01
ATC
levothyroxine sodium; systemic
1.4
17.5
888
6684
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
17.4
1233
9868
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
17.3
956
7309
LFA00
NOMESCO Finland
Incision of vulva or perineum
12.0
17.3
31
26
X15
ICPC
Vaginal symptom/complaint other
2.7
17.0
121
466
T90
ICPC
Diabetes non-insulin dependent
1.5
16.8
646
4581
N76.2
ICD-10 Finland
Acute vulvitis
7.2
16.7
40
56
A02BC03
ATC
lansoprazole; oral
1.4
16.7
940
7203
A63.0
ICD-10 Finland
Anogenital (venereal) warts
2.7
16.6
114
428
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
16.5
1089
8585
8071/2-C51.9
ICD-O-3
Differentiated intraepithelial neoplasia of vulva, NOS
170.8
16.5
17
*
N94.1
ICD-10 Finland
Dyspareunia
4.8
16.5
54
113
8077/2-C51.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vulva, NOS
20.1
16.4
24
12
L90
ICD-10 Finland
Atrophic disorders of skin
40.3
16.3
20
5
A02BC02
ATC
pantoprazole; systemic
1.4
16.2
2082
18301
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
16.1
669
4816
M79.6
ICD-10 Finland
Pain in limb
1.4
16.1
1135
9040
Z01.2
ICD-10 Finland
Dental examination
1.4
16.1
1247
10094
XKD00
NOMESCO Finland
Uroflowmetry
1.9
16.1
235
1267
D07.1
ICD-10 Finland
Carcinoma in situ: Vulva
21.0
16.0
23
11
R05
ICD-10 Finland
Cough
1.5
15.9
613
4341
XQ848
NOMESCO Finland
Dermatological photography
3.1
15.8
86
280
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.7
15.8
361
2246
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
13.0
15.6
27
21
N81.6
ICD-10 Finland
Rectocele
1.8
15.4
300
1779
R06AX27
ATC
desloratadine; oral
1.4
15.4
820
6203
L93.0
ICD-10 Finland
Discoid lupus erythematosus
38.2
15.4
19
5
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
15.4
653
4723
J02AC02
ATC
itraconazole; systemic
1.5
15.2
597
4243
N35.9
ICD-10 Finland
Urethral stricture, unspecified
7.3
15.2
36
50
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.8
15.1
287
1687
WX110
NOMESCO Finland
Local anesthesy
1.3
15.1
2098
18561
N02BE01
ATC
paracetamol; systemic, rectal
1.5
15.0
2820
26254
SPAT1310
SPAT
Counselling related to known health issue
1.4
14.8
978
7675
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
14.8
460
3097
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
14.8
1948
17058
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
14.8
927
7213
N95.0
ICD-10 Finland
Postmenopausal bleeding
1.6
14.7
377
2419
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
14.6
209
1116
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
14.4
458
3104
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
14.3
1657
14206
C05AA08
ATC
fluocortolone; rectal, topical
1.6
14.0
441
2978
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
2.5
13.9
112
463
D07CC01
ATC
betamethasone and antibiotics; topical
1.6
13.9
375
2439
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
1.7
13.9
301
1845
TQW80
NOMESCO Finland
Local dermatologic skincare
3.0
13.8
79
265
R06AE07
ATC
cetirizine; oral
1.3
13.8
1377
11516
N76.1
ICD-10 Finland
Subacute and chronic vaginitis
3.3
13.8
69
213
M54.5
ICD-10 Finland
Low back pain
1.4
13.6
1002
7989
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.7
13.6
45
96
G47.3
ICD-10 Finland
Sleep apnoea
1.5
13.6
524
3703
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
13.5
806
6204
N48.5
ICD-10 Finland
Ulcer of penis
140.5
13.5
14
*
D02AX
ATC
Other emollients and protectives
2.5
13.4
103
418
WX320
NOMESCO Finland
Spinalanesthesy
1.4
13.3
670
4996
L29.0
ICD-10 Finland
Pruritus ani
5.4
13.3
39
73
L08
ICPC
Shoulder symptom/complaint
1.4
13.1
589
4296
103
Kela drug reimbursment
Diabetes, insulin-treated
1.4
13.1
689
5177
TKD00
NOMESCO Finland
Dilatation of urethra
4.3
13.0
47
110
D02AE01
ATC
carbamide; topical
1.9
13.0
202
1115
WX240
NOMESCO Finland
Penis blockade
28.5
12.9
17
6
C51.81
ICD-10 Finland
Squamous cell carcinoma of the vulva
28.5
12.9
17
6
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.6
12.9
352
2297
L43.0
ICD-10 Finland
Hypertrophic lichen planus
5.2
12.8
39
76
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
12.8
805
6238
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
12.8
2874
27021
N90.5
ICD-10 Finland
Atrophy of vulva
10.5
12.7
24
23
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
1.7
12.7
243
1435
SPAT1263
SPAT
Sampling
1.3
12.7
1287
10752
K59.1
ICD-10 Finland
Functional diarrhoea
2.0
12.6
163
839
A02BC05
ATC
esomeprazole; systemic
1.3
12.6
1276
10648
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.2
12.5
131
618
L30.4
ICD-10 Finland
Erythema intertrigo
3.8
12.5
51
134
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
12.5
1254
10452
L91.0
ICD-10 Finland
Hypertrophic scar
10.1
12.5
24
24
LFD10
NOMESCO Finland
Vulvectomy and excision of regional lymph nodes
20.1
12.4
18
9
S29
ICPC
Skin symptom/complaint other
1.5
12.4
499
3551
P01AB01
ATC
metronidazole; oral, rectal
1.3
12.3
1259
10516
J01MA02
ATC
ciprofloxacin; systemic
1.3
12.2
1073
8759
D01AA02
ATC
natamycin; topical
2.8
12.1
76
274
A10BA02
ATC
metformin; oral
1.4
12.1
725
5565
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.7
12.1
251
1518
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
12.1
1410
11985
S18
ICPC
Laceration/cut
1.3
12.1
1194
9918
KDH10
NOMESCO Finland
Meatoplasty of urethra
18.1
12.0
18
10
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
12.0
1180
9786
R03AC02
ATC
salbutamol; inhalant
1.3
12.0
1606
13904
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
7.2
12.0
28
39
D07XC01
ATC
betamethasone, combinations; topical
1.6
12.0
315
2034
A10BH01
ATC
sitagliptin; oral
1.7
11.9
249
1507
EKA10
NOMESCO Finland
Biopsy of cheek
2.8
11.9
76
278
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
11.7
1097
9026
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
11.6
814
6405
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
11.6
692
5303
LFD00
NOMESCO Finland
Vulvectomy
65.2
11.6
13
*
N77.1*B37.3
ICD-10 Finland
Candidiasis of vulva and vagina
3.2
11.6
59
186
L29.3
ICD-10 Finland
Anogenital pruritus, unspecified
23.0
11.6
16
7
H02AB06
ATC
prednisolone; systemic
1.3
11.3
1370
11668
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.7
11.2
231
1392
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
11.2
441
3121
A98
ICPC
Health maint/preventive medicine
1.7
11.1
3196
30900
M01AH05
ATC
etoricoxib; oral
1.3
11.1
1803
15947
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.4
11.0
730
5692
SPAT1153
SPAT
Removal of sutures
1.3
10.9
940
7626
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.7
10.9
254
1585
SPAT1301
SPAT
No procedures
1.3
10.9
944
7666
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
10.9
955
7771
G04BD08
ATC
solifenacin; oral
1.7
10.8
218
1308
N76.0
ICD-10 Finland
Acute vaginitis
1.9
10.7
148
782
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
2.1
10.7
120
584
SPAT1262
SPAT
Handing over of treatment supplies
1.4
10.6
476
3461
K03.64
ICD-10 Finland
Dental calculus supragingival
1.3
10.5
782
6201
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.9
10.5
156
849
L28.0
ICD-10 Finland
Lichen simplex chronicus
3.8
10.4
43
115
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
10.3
539
4026
G03CC04
ATC
estrone; systemic
1.9
10.3
155
847
C51.9
ICD-10 Finland
Malignant neoplasm: Vulva, unspecified
10.6
10.3
19
18
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
10.3
217
1322
D07AC14
ATC
methylprednisolone aceponate; topical
1.9
10.2
142
751
R01AD09
ATC
mometasone; nasal
1.3
10.2
1353
11610
Z2221
NOMESCO Finland
Medical doctor
1.3
10.2
796
6350
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
10.2
688
5365
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.8
10.1
172
982
N84.0
ICD-10 Finland
Polyp of corpus uteri
1.6
10.0
287
1890
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
11.3
10.0
18
16
M70.6
ICD-10 Finland
Trochanteric bursitis
1.4
10.0
450
3271
R06.0
ICD-10 Finland
Dyspnoea
1.3
9.9
711
5599
LCA13
NOMESCO Finland
Curettage of cervix and body of uterus
1.6
9.8
251
1606
L30.8
ICD-10 Finland
Other specified dermatitis
2.7
9.8
64
239
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
9.8
524
3930
K02.1
ICD-10 Finland
Caries of dentine
1.3
9.8
1599
14059
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
9.7
349
2423
R42
ICD-10 Finland
Dizziness and giddiness
1.3
9.7
663
5183
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
9.7
1545
13539
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
9.6
1349
11636
K60.1
ICD-10 Finland
Chronic anal fissure
2.5
9.6
72
291
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.6
9.5
66
256
ULC02
NOMESCO Finland
Hysteroscopy
1.7
9.4
192
1157
L90.4
ICD-10 Finland
Acrodermatitis chronica atrophicans
+∞
9.4
9
*
E000007
ATC
NA
1.8
9.3
150
839
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
9.3
1657
14686
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.4
9.3
575
4418
L01
ICPC
Neck symptom/complaint
1.4
9.2
409
2966
A60.0
ICD-10 Finland
Herpesviral infection of genitalia and urogenital tract
3.2
9.1
45
140
L17
ICPC
Foot/toe symptom/complaint
1.3
9.1
730
5835
J01CA04
ATC
amoxicillin; systemic
1.3
9.1
2487
23166
G03CB01
ATC
dienestrol; oral, vaginal
1.9
9.1
129
693
R53
ICD-10 Finland
Malaise and fatigue
1.4
9.1
572
4407
N90.3
ICD-10 Finland
Dysplasia of vulva, unspecified
36.8
9.0
11
*
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
1.9
8.9
118
617
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
8.9
483
3624
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
8.9
604
4705
N30.0
ICD-10 Finland
Acute cystitis
1.4
8.9
462
3446
D01AC02
ATC
miconazole; topical
1.7
8.9
195
1198
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.3
8.8
763
6163
H01
ICPC
Ear pain/earache
1.5
8.8
283
1920
SPAT1312
SPAT
General health counselling
1.3
8.7
919
7618
S21
ICPC
Skin texture symptom/complaint
1.5
8.7
349
2476
M25.5
ICD-10 Finland
Pain in joint
1.3
8.7
835
6837
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
3.7
8.7
36
98
SPAT1260
SPAT
Consultation of another employee
1.4
8.7
506
3845
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
1.7
8.7
168
999
Z70.8
ICD-10 Finland
Other sex counselling
7.6
8.6
19
25
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
8.6
1034
8721
A02BA02
ATC
ranitidine; systemic
1.3
8.6
577
4490
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.4
8.5
520
3985
D11
ICPC
Diarrhoea
1.5
8.4
291
2003
8474
FHL
Coagulation, excision, or biopsy of local change (eg, condyloma, tumor) in operating room or anesthesia
6.0
8.4
22
37
L90.8
ICD-10 Finland
Other atrophic disorders of skin
90.3
8.4
9
*
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.5
8.4
321
2259
A01AB09
ATC
miconazole; local oral
1.5
8.4
281
1921
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.9
8.3
109
570
R05
ICPC
Cough
1.3
8.2
642
5102
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
8.2
569
4443
R35
ICD-10 Finland
Polyuria
1.8
8.2
144
832
N81.1
ICD-10 Finland
Cystocele
1.5
8.2
276
1890
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
6.5
8.2
20
31
N76.8
ICD-10 Finland
Other specified inflammation of vagina and vulva
3.1
8.2
42
136
ZXE00
NOMESCO Finland
One hour or less
1.3
8.1
1131
9695
H04.10
ICD-10 Finland
Dry eye syndrome
1.5
8.1
302
2112
R30.0
ICD-10 Finland
Dysuria
1.9
8.1
105
547
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.7
8.1
169
1027
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.4
8.1
432
3236
C51.00
ICD-10 Finland
Malignant tumor of the labium majus without histology
17.2
8.1
12
7
J05AB11
ATC
valaciclovir; oral
1.4
8.0
375
2742
X01
ICPC
Genital pain female
3.7
8.0
33
90
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
8.0
1727
15523
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.5
8.0
295
2063
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
7.9
376
2756
Y04
ICPC
Penis symptom/complaint other
7.8
7.9
17
22
J01CA08
ATC
pivmecillinam; oral
1.2
7.8
1512
13418
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.2
7.8
1160
10008
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.4
7.8
374
2752
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
7.8
1294
11302
L90.6
ICD-10 Finland
Striae atrophicae
45.1
7.7
9
*
SBA00
NOMESCO Finland
Microbiological examinations
2.2
7.7
75
348
H13
ICPC
Plugged feeling ear
1.4
7.7
471
3605
L82
ICD-10 Finland
Seborrhoeic keratosis
1.4
7.7
399
2970
D06BB10
ATC
imiquimod; topical
1.8
7.7
121
674
R32
ICD-10 Finland
Unspecified urinary incontinence
2.0
7.7
99
513
D01
ICPC
Abdominal pain/cramps general
1.5
7.7
294
2072
E000002
ATC
NA
1.5
7.6
288
2019
M01AE02
ATC
naproxen; oral, rectal
1.2
7.6
1677
15072
M03BX02
ATC
tizanidine; oral
1.2
7.6
1892
17221
J01FF01
ATC
clindamycin; systemic
1.3
7.6
715
5825
J05AB01
ATC
aciclovir; systemic
1.3
7.5
619
4954
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
4.6
7.5
24
52
L03
ICPC
Low back symptom/complaint
1.3
7.5
717
5858
A46
ICD-10 Finland
Erysipelas
1.4
7.4
317
2280
N77.8
ICD-10 Finland
Vulvovaginal ulceration and inflammation in other diseases classified elsewhere
13.4
7.4
12
9
R01AD12
ATC
fluticasone furoate; nasal
1.3
7.4
813
6758
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
7.3
280
1967
Z00.0
ICD-10 Finland
General medical examination
1.3
7.3
492
3825
ZXC50
NOMESCO Finland
Cryotherapy
2.2
7.3
69
317
U02
ICPC
Urinary frequency/urgency
1.4
7.2
424
3224
L57.0
ICD-10 Finland
Actinic keratosis
1.5
7.2
240
1642
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
1.6
7.2
164
1025
N02AX02
ATC
tramadol; systemic, rectal
1.2
7.2
1172
10188
8070/3-C51.1
ICD-O-3
Squamous cell carcinoma, NOS, of labium minus
30.1
7.1
9
*
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.4
7.1
283
2009
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
7.1
1083
9340
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
6.6
7.1
17
26
B37.3
ICD-10 Finland
Candidiasis of vulva and vagina
2.8
7.1
42
150
E66.00
ICD-10 Finland
Metabolic syndrome
1.8
7.1
125
723
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
7.0
1989
18273
G04BD07
ATC
tolterodine; oral
1.6
7.0
165
1039
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.4
7.0
291
2083
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.4
7.0
280
1990
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.2
7.0
65
297
N06AB04
ATC
citalopram; systemic
1.3
7.0
633
5131
D28.0
ICD-10 Finland
Benign neoplasm: Vulva
4.9
7.0
21
43
H29
ICPC
Ear symptom/complaint other
1.4
6.9
286
2040
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.4
6.9
283
2020
R07.0
ICD-10 Finland
Pain in throat
1.6
6.9
151
934
N06AX21
ATC
duloxetine; oral
1.4
6.9
308
2234
T86
ICPC
Hypothyroidism/myxoedema
1.7
6.8
132
788
B37.4
ICD-10 Finland
Candidiasis of other urogenital sites
8.3
6.8
14
17
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
6.8
814
6827
104
Kela drug reimbursment
Thyroid insufficiency
1.5
6.8
260
1830
T82
ICPC
Obesity
1.9
6.8
98
532
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.8
6.7
113
643
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
6.7
613
4967
M79.1
ICD-10 Finland
Myalgia
1.4
6.7
354
2645
SPAT1240
SPAT
Therapeutic discussion
1.5
6.7
254
1784
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.3
6.7
628
5108
A04
ICPC
Weakness/tiredness general
1.4
6.7
335
2482
R21
ICPC
Throat symptom/complaint
1.3
6.7
498
3927
A02BDXX
ATC
NA
1.8
6.7
107
603
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.3
6.7
407
3116
TKC22
NOMESCO Finland
Catheterisation instruction
2.6
6.6
44
169
A02BC01
ATC
omeprazole; systemic
1.3
6.6
792
6634
G04BD04
ATC
oxybutynin; oral, transdermal
1.6
6.6
172
1109
R10.2
ICD-10 Finland
Pelvic and perineal pain
2.3
6.6
56
243
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.4
6.6
295
2140
N03AX16
ATC
pregabalin; oral
1.3
6.6
675
5552
A10BK03
ATC
empagliflozin; oral
1.6
6.6
159
1006
L40.0
ICD-10 Finland
Psoriasis vulgaris
1.8
6.6
99
547
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.5
6.5
249
1753
R5140
NOMESCO Finland
Monitoring the use of the aid
1.5
6.5
242
1695
A06AC51
ATC
ispaghula, combinations; systemic
1.6
6.5
149
932
L29.9
ICD-10 Finland
Pruritus, unspecified
2.2
6.5
62
287
P03
ICPC
Feeling depressed
1.5
6.5
213
1452
R06AE09
ATC
levocetirizine; oral
1.4
6.5
391
2985
WZA90
NOMESCO Finland
Other doctors statement
1.3
6.4
615
5013
DHB50
NOMESCO Finland
Turbinoplasty
2.3
6.4
56
249
G01AF01
ATC
metronidazole; vaginal
1.4
6.4
356
2680
L98.1
ICD-10 Finland
Factitial dermatitis
70.0
6.4
7
*
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.8
6.4
112
647
R13
ICD-10 Finland
Dysphagia
1.6
6.4
162
1040
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.3
6.4
55
242
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.4
6.4
382
2914
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
6.4
638
5231
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
3.1
6.4
32
104
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
6.3
320
2375
U01
ICPC
Dysuria/painful urination
1.5
6.3
233
1633
TLC02
NOMESCO Finland
Simple extraction of IUD
1.8
6.3
104
595
D29.0
ICD-10 Finland
Benign neoplasm: Penis
+∞
6.2
6
*
L90.3
ICD-10 Finland
Atrophoderma of Pasini and Pierini
+∞
6.2
6
*
8070/3-C51.0
ICD-O-3
Squamous cell carcinoma, NOS, of labium majus
26.7
6.2
8
*
LFE00
NOMESCO Finland
Suture of vulva
26.7
6.2
8
*
L13
ICPC
Hip symptom/complaint
1.3
6.2
489
3884
L98.88
ICD-10 Finland
Other specified disorders of skin and subcutaneous tissue
7.0
6.2
14
20
D01AC03
ATC
econazole; topical
1.6
6.2
155
991
R51.80
ICD-10 Finland
Headache
1.3
6.2
387
2970
S76
ICPC
Skin infection other
1.7
6.2
122
733
XQ802
NOMESCO Finland
Epicutan test
1.7
6.1
111
650
K05.08
ICD-10 Finland
Another acute gingivitis
2.2
6.1
59
276
B07.9
ICD-10 Finland
Verruca simplex
2.0
6.1
73
373
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.3
6.1
471
3733
R06.5
ICD-10 Finland
Mouth breathing
1.5
6.1
189
1275
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
6.1
536
4321
R01AD08
ATC
fluticasone; nasal
1.2
6.1
795
6721
KMAK
NOMESCO Finland
NA
1.2
6.1
1462
13145
XKC03
NOMESCO Finland
Water cystometry
1.8
6.1
96
538
LDA10
NOMESCO Finland
Curettage of cervix uteri
1.7
6.0
114
677
R33
ICD-10 Finland
Retention of urine
1.7
6.0
107
624
D06BB03
ATC
aciclovir; topical
1.6
6.0
147
936
M01AB05
ATC
diclofenac; systemic, rectal
1.2
6.0
1989
18409
R06AX22
ATC
ebastine; oral
1.3
6.0
484
3858
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768443) Skin Pathology biopsy report
437
1343
3.54
117.67
1.3
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
240
475
5.32
115.26
1.6
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
2128
14029
2.14
114.85
2.6
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1220
6774
2.17
99.59
1.5
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
2790
22511
1.85
62.23
5.5
4.7
e6/l
1004.4
2641.9
1.93
25
303
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
86
116
7.56
60.22
1.6
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
2802
23168
1.75
51.28
5.2
4.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
156
482
3.33
40.97
1.5
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3491
31515
2.06
40.50
6.2
5.2
mu/l
2.5
2.1
0.37
3211
28723
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3110
27215
1.71
38.26
5.1
4.4
pmol/l
14.9
14.9
0.36
2830
24610
(3009261) Glucose [Presence] in Urine by Test strip
2099
16795
1.54
37.35
4.6
3.9
estimate
0.0
0.0
1.43
392
2997
(3021601) Nitrite [Presence] in Urine by Test strip
2077
16634
1.53
36.41
6.0
5.2
estimate
0.0
0.0
0.32
402
2975
(3026008) Bacteria identified in Urine by Culture
1541
11638
1.54
34.98
3.7
3.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2906
25234
1.60
34.12
4.6
4.1
mm/h
13.1
12.9
0.30
2707
23201
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
293
1383
2.21
33.23
1.4
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
107
299
3.65
32.82
1.2
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
2042
16512
1.50
32.66
4.6
3.9
estimate
0.0
0.0
0.50
394
2988
(3000494) Fungus identified in Specimen by Culture
612
3739
1.76
32.53
1.5
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3584
33203
2.02
30.39
14.9
13.4
mg/l
21.2
22.1
0.80
2892
26119
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2964
26230
1.55
28.31
7.3
7.3
u/l
78.8
78.6
0.12
2780
24505
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1051
7588
1.53
27.94
1.3
1.3
u/ml
1.5
1.7
0.24
291
1995
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3745
35438
2.54
27.76
11.5
10.4
u/l
24.9
24.6
0.40
3627
34078
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
48
83
5.84
26.62
1.9
1.8
ug/l
2.1
2.6
0.28
33
42
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3519
32692
1.81
25.43
5.3
4.6
mmol/l
6.0
5.9
5.05
3210
29606
(3019198) Lymphocytes [#/volume] in Blood
2004
16635
1.42
24.99
5.8
5.6
e9/l
1.9
1.9
0.85
1779
14500
(3018095) Leukocytes [#/volume] in Urine
1462
11476
1.44
24.82
3.8
3.5
e6/l
82.6
122.7
1.86
1034
7794
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3597
33685
1.91
24.71
5.6
5.0
mmol/l
2.8
2.8
2.12
3295
30739
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3360
30876
1.65
24.62
6.8
5.6
mmol/mol
40.5
39.5
7.28
3107
28306
(3013115) Eosinophils [#/volume] in Blood
2018
16837
1.41
24.06
5.8
5.8
e9/l
0.2
0.2
3.16
1787
14607
(3001604) Monocytes [#/volume] in Blood
1950
16185
1.41
23.88
5.7
5.6
e9/l
0.6
0.6
0.67
1694
13801
(3019550) Sodium [Moles/volume] in Serum or Plasma
3660
34526
2.02
23.82
17.3
15.4
mmol/l
139.7
139.7
0.25
3569
33635
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1711
13907
1.41
23.50
3.0
2.7
ug/l
99.4
112.6
1.52
1562
12741
(3006315) Basophils [#/volume] in Blood
1955
16262
1.41
23.48
5.8
5.6
e9/l
0.0
0.0
0.22
1699
13870
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1731
14102
1.41
23.44
2.1
2.0
pmol/l
100.7
98.1
1.17
856
6635
(3007853) Bacteria identified in Skin by Aerobe culture
536
3433
1.65
23.37
1.7
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3532
32991
1.77
23.09
5.1
4.4
mmol/l
4.7
4.8
7.99
3275
30239
(3023103) Potassium [Moles/volume] in Serum or Plasma
3663
34612
2.01
22.98
17.5
15.5
mmol/l
4.0
3.9
0.63
3558
33656
(3007164) IgA [Mass/volume] in Serum or Plasma
882
6385
1.49
22.35
1.4
1.4
g/l
2.4
2.3
0.34
519
3679
(3048689) Calprotectin [Mass/mass] in Stool
620
4161
1.58
22.24
2.3
2.1
ug/g
155.0
128.5
0.65
491
3205
(3009508) Creatinine [Moles/volume] in Urine
1283
9986
1.43
22.18
3.2
3.0
mmol/l
6.6
6.7
0.28
1070
8268
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3400
31513
1.63
21.95
4.4
3.9
mmol/l
1.3
1.3
2.62
3094
28429
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3506
32754
1.72
21.92
4.9
4.4
mmol/l
1.5
1.6
11.33
3201
29847
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1557
12589
1.39
21.40
4.9
4.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1221
9473
1.42
21.29
3.4
3.1
mg/l
365.2
415.4
0.14
755
5402
(3020682) Albumin/Creatinine [Ratio] in Urine
1275
9970
1.41
21.25
4.2
3.8
mg/mmol
6.0
7.9
1.01
782
5705
(3020564) Creatinine [Moles/volume] in Serum or Plasma
3710
35315
2.10
21.22
17.8
15.8
umol/l
72.5
71.9
0.70
3710
35307
(3007461) Platelets [#/volume] in Blood
3814
36745
2.99
21.10
23.0
20.2
e9/l
258.5
258.3
0.07
3724
35747
(3035941) MCH [Entitic mass]
3815
36763
3.01
21.03
22.9
20.1
pg
30.1
30.2
2.15
3771
36202
(3024731) MCV [Entitic volume]
3815
36763
3.01
21.03
22.9
20.1
fl
90.9
91.1
1.69
3770
36205
(3026361) Erythrocytes [#/volume] in Blood
3815
36767
3.00
20.95
23.0
20.2
e12/l
4.5
4.4
2.44
3707
35650
(3010813) Leukocytes [#/volume] in Blood
3815
36772
3.00
20.85
23.0
20.2
e9/l
6.5
6.6
1.06
3712
35645
(3000963) Hemoglobin [Mass/volume] in Blood
3815
36777
2.99
20.74
23.1
20.3
g/l
133.5
133.1
1.11
3774
36224
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1332
10536
1.40
20.63
2.5
2.4
u/l
53.8
58.2
3.95
1221
9638
(3037522) Nuclear Ab [Titer] in Serum
643
4456
1.53
19.81
1.4
1.3
titre
562.4
575.7
0.06
149
973
(3029937) Albumin [Presence] in Urine by Test strip
1143
8861
1.41
19.69
5.1
4.3
estimate
0.0
0.0
0.43
406
2959
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3388
31544
1.58
19.49
13.9
12.6
ml/min/173m2
78.5
79.1
0.96
2798
25873
(36304419) Bacteria [Presence] in Urine
1124
8719
1.41
19.20
3.2
2.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
2215
19173
1.36
18.99
8.2
9.0
e9/l
4.0
4.0
0.02
1943
16636
(3002582) Erythrocytes [#/volume] in Urine
1216
9594
1.39
18.68
3.3
3.0
e6/l
59.2
69.1
0.15
921
7152
(3030467) Casts [#/volume] in Urine by Automated count
1140
8922
1.39
18.31
3.2
2.9
e6/l
0.3
0.5
1.60
857
6589
(3011397) Hemoglobin [Presence] in Urine by Test strip
1032
7992
1.40
17.49
4.5
3.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1792
15147
1.34
17.30
2.3
2.3
nmol/l
78.6
79.7
0.93
1585
13494
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
380
2402
1.65
17.23
2.1
2.0
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1733
14624
1.33
16.71
4.7
4.3
g/l
35.7
35.6
0.09
1628
13456
(3000850) Epithelial cells [#/volume] in Urine
879
6668
1.41
16.68
2.6
2.4
e6/l
6.5
7.1
0.46
736
5782
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1030
8051
1.38
16.31
2.4
2.2
mg/l
3.0
3.0
0.38
885
6868
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
822
6206
1.41
15.94
1.3
1.3
iu/ml
29.7
34.4
0.37
234
1987
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
341
2149
1.64
15.61
2.1
1.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2241
19728
1.32
15.58
2.9
2.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
408
2696
1.57
15.35
3.8
3.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1810
15495
1.31
15.25
5.8
5.6
%
56.6
56.8
0.28
1659
14361
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2023
17588
1.31
15.23
5.6
5.9
umol/l
10.4
10.7
0.81
1912
16589
(3002030) Lymphocytes/100 leukocytes in Blood
1831
15707
1.31
15.17
6.0
5.9
%
28.4
28.5
0.16
1679
14496
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
733
5479
1.42
14.94
2.7
2.6
e6/l
1.1
1.4
1.59
419
2997
(3015171) Extractable nuclear Ab [Units/volume] in Serum
229
1310
1.79
14.91
1.2
1.2
u/ml
0.3
1.2
1.98
27
132
(3044889) 12 lead EKG panel
2628
23739
1.33
14.81
4.1
3.7
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
1777
15216
1.31
14.78
5.9
5.8
%
3.0
2.8
1.99
1622
14057
(3022096) Basophils/100 leukocytes in Blood
1729
14776
1.31
14.48
6.0
5.8
%
0.7
0.7
0.05
1585
13655
(3019069) Monocytes/100 leukocytes in Blood
1784
15314
1.30
14.44
6.2
6.1
%
8.4
8.5
0.84
1639
14214
(3022145) Colonoscopy Study observation
544
3877
1.47
14.29
1.3
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
815
6253
1.38
14.16
1.8
1.7
nmol/l
1209.8
1199.9
0.10
635
4658
(3019150) Specific gravity of Urine by Refractometry
920
7200
1.36
14.13
5.3
4.4
kg/l
1.0
1.0
0.09
133
1107
(3013826) Glucose [Moles/volume] in Serum or Plasma
2185
19302
1.30
14.12
4.2
4.2
mmol/l
6.8
6.6
1.33
2039
17950
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1984
17307
1.30
14.09
5.7
6.0
mmol/l
1.2
1.2
0.49
1692
14476
(40761511) CBC panel - Blood by Automated count
3607
34523
1.62
13.46
14.4
12.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1005
8027
1.34
13.39
2.4
2.3
umol/l
5166.9
4982.4
0.05
850
6839
(42870588) Differential panel, method unspecified - Blood
1326
11021
1.31
13.32
6.0
5.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2363
21184
1.29
13.20
3.2
3.0
u/l
46.2
45.2
0.18
2196
19471
(3042936) Bacteria identified in Isolate by Culture
577
4222
1.43
13.11
1.8
1.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1806
15662
1.29
13.01
4.9
5.3
mmol/l
1.2
1.2
0.18
1636
14023
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
665
5008
1.40
12.79
2.9
2.7
e6/l
4.2
3.9
0.16
357
2548
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
352
2360
1.54
12.36
1.7
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1073
8743
1.31
12.24
4.0
3.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
929
7421
1.33
12.18
1.8
1.7
pmol/l
49531908.9
33020255.0
0.36
747
6060
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
225
1372
1.68
11.71
2.2
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
178
1017
1.79
11.68
1.8
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1142
9455
1.29
11.41
2.8
2.9
ng/l
1118.4
1171.0
0.18
980
7994
(40768797) Stomach Pathology biopsy report
642
4901
1.37
11.26
1.3
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
369
2550
1.49
11.22
2.7
4.0
u/ml
72.8
61.1
0.12
357
2460
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
753
5897
1.34
11.19
1.3
1.3
u/ml
9.5
13.5
0.93
269
2223
(3021589) Normoblasts [#/volume] in Blood
1672
14573
1.26
10.82
10.0
9.2
e9/l
0.0
0.0
1.01
1388
11856
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
183
1080
1.73
10.75
2.3
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
963
7856
1.30
10.63
1.5
1.5
nmol/l
21.8
21.7
0.08
810
6588
(36660697) Celiac disease serology panel - Serum
387
2730
1.46
10.60
1.2
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
780
6200
1.32
10.38
2.9
2.6
mosm/kgh2o
532.2
515.5
1.31
641
5231
(3015377) Calcium [Moles/volume] in Serum or Plasma
1432
12306
1.26
10.32
3.1
3.3
mmol/l
2.4
2.4
0.31
1232
10616
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
832
6682
1.31
10.27
2.8
3.0
mmol/l
2.5
2.5
0.90
706
5858
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1198
10097
1.27
10.13
2.1
2.1
u/l
151.5
184.3
1.19
1124
9384
(42529406) Shigella sp [Presence] in Stool by Culture
174
1031
1.72
10.10
1.3
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
903
7373
1.29
9.79
1.7
1.7
mg/l
1.1
1.2
0.31
695
5624
(3002256) Pathology report gross observation
568
4358
1.36
9.54
1.2
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
275
1850
1.52
9.51
1.3
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1441
12484
1.25
9.43
3.7
3.5
ng/l
25.9
81.0
0.84
950
8409
(3014765) Yersinia sp identified in Stool by Organism specific culture
170
1028
1.68
9.18
1.3
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
161
962
1.70
9.09
2.0
1.7
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
154
911
1.72
9.02
1.3
1.2
u/ml
10.1
49.4
—
8
56
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1100
9288
1.26
8.93
1.8
1.6
mmol/l
1.4
1.4
0.79
896
7760
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
361
2599
1.43
8.86
2.1
2.3
ug/l
3.9
6.5
5.06
314
2224
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
167
1022
1.66
8.64
1.3
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
294
2056
1.47
8.43
1.3
1.3
au/ml
57.7
44.5
0.34
11
100
(40760892) CBC W Ordered Manual Differential panel - Blood
854
7041
1.27
8.40
4.1
4.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
777
6337
1.28
8.34
4.0
3.6
ng/l
237.3
317.8
0.39
569
4881
(3018418) pH of Serum or Plasma
1217
10458
1.24
8.33
3.6
3.7
ph
7.4
7.4
0.49
219
1980
(3019832) Treponema pallidum Ab [Presence] in Serum
281
1954
1.47
8.29
1.7
1.6
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
116
661
1.78
7.79
1.3
1.2
u/ml
1.2
3.2
—
10
57
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
139
839
1.68
7.62
1.3
1.3
u/ml
1.9
7.7
2.61
28
154
(3022948) Iron [Moles/volume] in Serum or Plasma
604
4825
1.30
7.56
2.3
2.3
umol/l
13.1
12.8
0.34
559
4429
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
274
1933
1.45
7.52
2.5
2.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
643
5186
1.29
7.47
3.1
3.0
mmol/l
0.8
0.8
0.42
593
4791
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
672
5460
1.28
7.36
1.5
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
241
1668
1.47
7.31
1.5
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
136
829
1.66
7.20
1.3
1.2
u/ml
7.2
5.8
0.11
20
98
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
117
685
1.73
7.19
1.3
1.2
u/ml
67.9
38.0
0.57
11
76
(3005322) IgE [Units/volume] in Serum or Plasma
284
2038
1.42
7.12
1.3
1.2
u/ml
184.3
185.9
0.02
262
1876
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
311
2271
1.40
7.06
2.5
2.4
au/ml
12.5
25.1
—
10
120
(3045414) Leukocytes [Presence] in Urine
231
1599
1.47
7.01
1.9
2.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2899
27404
1.23
6.98
18.3
16.6
%
13.7
13.7
0.50
2850
26779
(3039162) Centromere protein B Ab [Units/volume] in Serum
76
393
1.95
6.95
1.3
1.2
u/ml
53.0
59.3
—
7
27
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1722
15532
1.20
6.80
4.2
3.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
198
1340
1.50
6.73
2.4
2.0
u/l
40.8
39.5
0.38
175
1178
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
50
224
2.25
6.66
1.7
1.5
u/ml
11.7
15.8
1.13
12
40
(3014576) Chloride [Moles/volume] in Serum or Plasma
468
3699
1.30
6.31
5.5
6.0
mmol/l
104.2
104.2
0.09
462
3621
(3045683) HLA typing for celiac disease panel - Blood or Tissue
42
179
2.36
6.29
1.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
68
354
1.94
6.15
1.4
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
546
4422
1.27
6.08
2.3
2.3
g/l
2.4
2.4
0.04
499
4053
(3023520) Reticulocytes [#/volume] in Blood
327
2469
1.35
6.06
2.6
2.6
e9/l
70.3
71.3
0.23
251
1836
(40758558) Short blood count panel - Blood
989
8558
1.21
5.95
6.2
6.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
323
2446
1.35
5.88
1.2
1.2
iu/ml
160.8
139.6
0.40
125
929
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
43
192
2.25
5.82
1.3
1.4
titre
66.7
74.3
—
6
23
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
137
890
1.56
5.67
1.7
1.5
g/l
1.2
1.2
0.15
132
846
(3027945) Reticulocytes/100 erythrocytes in Blood
419
3311
1.30
5.66
2.4
2.5
%
1.8
1.8
0.38
370
2911
(3032080) INR in Blood by Coagulation assay
1433
12870
1.18
5.61
8.6
8.3
inr
1.2
1.2
0.02
421
3726
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
466
3738
1.28
5.60
2.8
2.4
umol/l
7.6
7.5
0.05
396
3181
(46235355) HIV 1 and 2 tests - Meaningful Use set
538
4416
1.25
5.33
1.9
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
157
1066
1.49
5.32
1.1
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
132
865
1.54
5.28
1.8
1.6
g/l
0.2
0.2
0.58
126
822
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
12
26
4.63
5.25
2.5
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
156
1062
1.49
5.22
1.4
1.4
ug/g
284.0
286.2
0.05
92
620
(40761536) Microorganisms panel - Urine sediment
365
2870
1.30
5.12
4.6
4.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
135
896
1.52
5.11
2.5
2.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
501
4100
1.25
5.09
2.3
2.3
%
21.9
21.8
0.06
420
3451
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
240
1781
1.37
5.01
3.3
3.5
kpa
5.0
5.2
2.31
224
1642
(4010399)
317
2455
1.32
4.98
1.4
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
128
845
1.53
4.97
2.8
2.1
mg/l
11.0
11.4
0.28
119
771
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
42
199
2.12
4.97
1.1
1.2
—
—
—
0
0
(4035726)
400
3197
1.28
4.95
1.5
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
106
671
1.60
4.95
2.7
2.9
mmol/l
24.2
25.4
2.71
94
589
(3022689) Creatine [Moles/volume] in Urine
24
88
2.74
4.93
1.8
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
237
1762
1.37
4.89
3.3
3.5
ph
7.4
7.4
0.52
40
235
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
229
1698
1.37
4.81
3.2
3.4
mmol/l
1.9
2.1
0.19
167
1288
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
42
203
2.08
4.74
1.1
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
950
8340
1.18
4.73
3.7
3.4
%
92.2
93.2
0.64
936
8101
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
11
25
4.41
4.56
1.0
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
213
1584
1.36
4.42
1.1
1.1
titre
70.2
184.4
—
6
38
(3013139) Helicobacter pylori Ag [Presence] in Stool
313
2462
1.30
4.41
1.3
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
103
668
1.56
4.38
2.5
2.3
ug/min
43.7
73.4
0.88
53
394
(3034274) Bile acid [Moles/volume] in Serum --fasting
52
280
1.87
4.36
1.8
2.0
umol/l
9.5
8.0
0.18
43
196
(3020630) Protein [Mass/volume] in Serum or Plasma
333
2646
1.28
4.34
2.5
2.5
g/l
67.0
66.6
0.38
307
2366
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1184
10645
1.16
4.32
3.3
3.2
u/l
31.9
32.6
0.22
1124
10045
(3030981) Hyaline casts [#/volume] in Urine by Automated count
201
1492
1.37
4.23
2.4
2.5
e6/l
0.2
0.3
0.45
196
1445
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
904
7969
1.18
4.23
2.4
2.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
173
1254
1.40
4.21
1.7
1.5
u/ml
27.3
16.1
—
6
29
(3044640) Blood type and Crossmatch panel - Blood
1170
10533
1.16
4.17
2.5
2.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
925
8190
1.17
4.08
4.3
3.9
—
—
—
0
0
(3013512) EKG study
1111
9990
1.16
3.99
3.9
3.8
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
554
4704
1.21
3.96
2.0
1.9
s
29.8
29.4
0.70
539
4546
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
227
1740
1.32
3.89
1.5
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
229
1758
1.32
3.88
1.1
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
593
5081
1.20
3.84
1.9
1.8
—
—
—
0
0
(3000492) Spirometry study
365
2989
1.24
3.72
1.4
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
114
785
1.47
3.71
1.2
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
132
935
1.43
3.70
1.3
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
233
1816
1.30
3.57
1.7
1.8
g/l
1.3
1.4
0.20
221
1633
(3005719) IgG [Mass/volume] in Serum or Plasma
286
2293
1.27
3.51
2.6
2.7
g/l
10.8
10.4
1.02
265
2072
(3028679) Herpes simplex virus Ab [Presence] in Serum
28
132
2.13
3.45
1.3
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
64
396
1.63
3.39
1.8
1.5
%
55.8
56.7
0.06
35
251
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
126
903
1.41
3.34
1.1
1.1
u/ml
8.5
6.6
0.11
12
97
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
172
1298
1.34
3.33
1.6
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
497
4249
1.19
3.31
7.5
6.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
241
1909
1.28
3.28
6.1
6.7
mmol/l
24.8
24.8
0.02
223
1755
(3044941) Cell count panel - Synovial fluid
76
496
1.54
3.24
1.4
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
248
1976
1.27
3.22
4.3
4.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
425
3597
1.20
3.16
1.7
1.6
—
—
—
0
0
(3020891) Body temperature
160
1206
1.34
3.14
3.8
4.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
85
574
1.49
3.11
1.6
1.5
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
14
50
2.81
3.08
1.4
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
8
16
5.01
3.05
4.6
2.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
65
416
1.57
3.04
1.3
1.4
u/l
28.4
35.9
1.22
54
341
(3014051) Protein [Presence] in Urine by Test strip
118
853
1.40
3.02
2.0
2.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
75
497
1.52
3.01
2.6
2.6
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
96
672
1.44
2.94
1.3
1.2
mmol/l
3.6
3.8
0.58
89
631
(3022217) INR in Platelet poor plasma by Coagulation assay
471
4053
1.18
2.92
22.8
23.2
inr
1.2
1.3
1.13
81
559
(3029075) Extractable nuclear Ab panel - Serum
19
82
2.32
2.91
1.1
1.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
9
22
4.10
2.88
1.2
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
329
2743
1.22
2.87
4.9
4.3
ug/l
2.4
2.1
0.23
287
2439
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
20
89
2.25
2.86
2.0
1.7
ug/l
9.0
9.0
0.01
20
89
(3016502) Oxygen saturation in Arterial blood
360
3031
1.21
2.85
5.6
6.9
%
95.7
95.8
0.17
349
2899
(3004588) Protein electrophoresis panel - Serum or Plasma
270
2208
1.24
2.84
2.1
2.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
121
890
1.37
2.81
1.4
1.2
titre
952.2
1055.0
—
9
32
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
39
223
1.76
2.81
1.2
1.1
titre
86.7
138.5
—
9
39
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
364
3073
1.20
2.80
2.2
2.1
g/l
0.2
0.2
0.02
332
2871
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
8
18
4.45
2.79
4.6
2.3
mg/l
23.9
21.2
—
8
18
(4024509)
60
386
1.56
2.77
1.7
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
937
8518
1.13
2.74
1.4
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
283
2337
1.23
2.73
3.0
3.1
pmol/l
4.3
4.5
1.55
252
2067
(3003396) Base excess in Arterial blood by calculation
402
3437
1.19
2.70
5.3
6.5
mmol/l
1.2
1.2
0.03
313
2705
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
11
37
2.98
2.69
1.0
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
379
3227
1.19
2.67
1.6
1.7
%
1.4
1.4
0.16
321
2833
(3022621) pH of Urine by Test strip
280
2318
1.22
2.64
3.5
3.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
300
2501
1.22
2.64
3.6
3.9
%
0.0
0.5
1.41
70
573
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
19
86
2.22
2.63
1.1
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
105
764
1.38
2.63
1.3
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
3070
29863
1.13
2.60
16.4
14.7
%
39.6
39.1
2.33
2103
20862
(3000475) Leukocytes [#/volume] in Synovial fluid
106
774
1.38
2.60
1.7
1.6
e6/l
8719.7
10816.4
0.31
76
563
(40767503) Oxygen content in Capillary blood by calculation
91
648
1.41
2.58
2.9
2.4
%
16.4
16.0
0.39
51
317
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
156
1.87
2.56
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
105
768
1.38
2.55
1.3
1.8
—
—
—
0
0
(4034850)
145
1114
1.31
2.55
11.3
9.7
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
30
164
1.84
2.53
1.2
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
97
702
1.39
2.52
1.3
1.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
325
2746
1.20
2.50
2.8
2.8
ng/l
162.6
176.7
0.40
293
2486
(3003458) Phosphate [Moles/volume] in Serum or Plasma
456
3971
1.17
2.47
4.9
4.6
mmol/l
1.0
1.0
1.53
424
3628
(3013293) Extractable nuclear Ab [Presence] in Serum
12
45
2.67
2.45
1.7
1.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
46
288
1.60
2.42
1.6
1.5
%
38.2
35.3
0.20
25
174
(3002173) Hemoglobin [Mass/volume] in Arterial blood
334
2842
1.19
2.39
5.9
7.2
g/l
120.2
119.7
0.22
320
2720
(3000764) Benzodiazepines [Presence] in Urine
103
761
1.36
2.38
1.3
1.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
131
1005
1.31
2.36
3.1
3.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
39
236
1.66
2.35
1.1
1.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
400
3463
1.17
2.34
5.2
6.5
kpa
5.1
5.1
0.22
379
3285
(3027944) Amphetamines [Presence] in Urine
102
755
1.36
2.33
1.3
1.6
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
39
237
1.65
2.31
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
39
237
1.65
2.31
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
39
237
1.65
2.31
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
39
237
1.65
2.31
1.1
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
73
511
1.44
2.31
1.1
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
354
3038
1.18
2.30
2.0
2.1
nmol/l
373.1
375.6
0.09
318
2783
(3027801) Oxygen [Partial pressure] in Arterial blood
399
3460
1.17
2.29
5.2
6.5
kpa
12.0
12.6
1.30
380
3281
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
109
818
1.34
2.29
1.6
1.6
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
39
238
1.65
2.28
1.1
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
300
2540
1.20
2.28
3.3
3.7
%
0.5
0.6
0.09
68
526
(3007566) Smooth muscle Ab [Titer] in Serum
116
882
1.32
2.24
1.3
1.2
titre
117.3
87.6
0.30
15
63
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
18
86
2.10
2.22
1.0
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
113
857
1.33
2.22
1.6
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
212
2566
0.82
2.20
1.8
1.7
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
8
24
3.34
2.18
1.0
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
440
3865
1.16
2.15
1.6
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
41
259
1.59
2.11
1.1
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
46
301
1.53
2.05
1.1
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
123
958
1.29
2.03
1.6
1.6
iu/ml
0.4
0.2
0.15
35
205
(1001926) Buprenorphine [Presence] in Urine by Screen method
81
595
1.37
1.99
1.3
1.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
158
1274
1.25
1.97
3.4
3.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2844
27683
1.10
1.96
20.5
17.7
g/l
330.6
331.1
2.13
2830
27479
(3000330) Specific gravity of Urine by Test strip
213
1775
1.21
1.95
3.7
3.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
103
788
1.32
1.95
1.3
1.2
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
5
11
4.55
1.94
1.0
1.0
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
6
16
3.75
1.93
1.0
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
85
633
1.35
1.93
3.3
3.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
321
2779
1.17
1.92
3.5
3.9
%
0.9
0.9
0.01
85
731
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
76
557
1.37
1.91
1.5
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
28
165
1.70
1.90
1.0
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
26
150
1.74
1.90
4.2
2.8
ph
7.4
7.4
0.29
12
49
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
31
188
1.65
1.90
1.1
1.5
u/l
4.7
5.7
0.87
24
155
(3047007) Chlamydophila sp Ab [Presence] in Serum
63
449
1.41
1.87
1.2
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
297
2562
1.17
1.86
2.7
2.5
ml/min/173m2
64.7
65.0
0.04
126
1011
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
66
476
1.39
1.83
2.2
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
362
3177
1.15
1.82
1.6
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
94
718
1.32
1.82
2.3
2.2
g/l
131.0
126.5
1.03
71
509
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
141
1135
1.25
1.81
3.6
3.7
mmol/l
25.1
25.1
0.01
131
1033
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
15
73
2.06
1.80
1.6
2.4
mmol/l
6.8
7.0
—
9
40
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
9
35
2.57
1.80
1.0
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
485
4349
1.13
1.78
4.9
4.6
%
32.2
33.2
1.41
330
2800
(3023410) Appearance of Cerebral spinal fluid
46
312
1.48
1.78
1.4
1.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
73
539
1.36
1.77
1.9
1.7
nmol/l
0.9
0.8
0.08
60
446
(3021440) Promyelocytes/100 leukocytes in Blood
306
2660
1.16
1.76
3.6
3.9
%
0.1
0.2
0.36
75
674
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
87
661
1.32
1.75
3.5
3.6
%
58.7
57.2
0.61
87
661
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
138
1113
1.25
1.75
1.8
1.9
ug/l
2.9
1.7
0.68
123
979
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
100
775
1.30
1.75
1.4
1.3
mg/l
608.1
514.6
0.47
95
737
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
16
81
1.98
1.74
1.0
1.1
%
98.2
89.5
—
9
38
(40768793) Breast Pathology biopsy report
90
1166
0.77
1.74
1.3
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
106
829
1.29
1.74
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
41
273
1.51
1.73
1.0
1.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
303
2635
1.16
1.73
4.4
5.9
mmol/l
1.3
1.3
0.26
296
2543
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
20
110
1.82
1.72
1.0
1.3
—
—
—
0
0
(1002224) Polysomnography panel
144
1170
1.24
1.72
1.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
7
24
2.92
1.72
1.3
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
24
2.92
1.72
1.0
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
23
133
1.73
1.69
1.6
2.3
%
103.3
97.2
0.43
23
124
(3014007) Fractional oxyhemoglobin in Arterial blood
218
1850
1.19
1.68
6.1
7.9
%
94.3
94.1
0.21
218
1845
(3025018) Bordetella pertussis Ab [Titer] in Serum
31
195
1.59
1.68
1.2
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
45
308
1.47
1.68
1.6
1.4
g/l
7.0
7.0
0.05
35
217
(4062490)
45
308
1.47
1.68
1.6
1.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
45
308
1.47
1.68
1.6
1.4
g/l
2.9
2.8
0.12
35
219
(3024139) IgG subclass 3 [Mass/volume] in Serum
45
308
1.47
1.68
1.6
1.4
g/l
0.4
0.4
0.27
35
217
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
34
219
1.56
1.67
1.1
1.1
iu/ml
5.6
12.2
—
6
55
(3045424) Erythrocytes [Presence] in Urine
77
580
1.33
1.66
1.5
1.6
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
68
504
1.36
1.63
2.1
1.7
mmol/l
1.8
1.6
0.70
68
492
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
23
135
1.71
1.62
1.1
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
49
344
1.43
1.61
1.1
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
32
2.50
1.59
2.1
1.3
—
—
—
0
0
(44813793)
35
230
1.53
1.59
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
15
77
1.95
1.59
1.6
1.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
133
1086
1.23
1.55
1.9
2.2
g/l
0.3
0.7
1.62
115
919
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
89
693
1.29
1.54
1.4
1.3
e6/l
34.1
25.4
0.25
63
525
(3012494) Peanut IgE Ab [Units/volume] in Serum
15
78
1.93
1.54
1.1
1.1
u/ml
0.9
2.5
—
6
36
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
109
871
1.26
1.54
1.3
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
69
519
1.34
1.53
1.4
2.5
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
5
15
3.34
1.52
2.8
2.1
mg/l
3.8
3.4
—
5
15
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
61
451
1.36
1.51
1.2
1.4
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
44
0.00
1.51
0.0
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
60
443
1.36
1.50
1.3
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
89
696
1.29
1.50
1.4
1.4
e6/l
6679.2
1210.9
0.71
67
558
(3034891) Synovial lining cells/100 cells in Synovial fluid
25
154
1.63
1.49
1.4
1.5
%
3.5
4.2
—
6
31
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
25
154
1.63
1.49
1.2
1.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
59
435
1.36
1.49
1.4
1.3
pmol/l
318.9
361.7
0.22
49
337
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
26
162
1.61
1.49
1.1
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
26
162
1.61
1.49
1.1
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
72
1.95
1.48
1.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
48
342
1.41
1.48
1.3
2.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
378
3380
1.13
1.48
3.3
3.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
335
2973
1.14
1.48
3.2
3.4
mmol/l
1.2
1.2
0.26
288
2561
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
101
805
1.26
1.47
1.3
1.3
miu/ml
201.9
216.3
0.14
48
382
(3016018) Differential panel - Cerebral spinal fluid
46
326
1.42
1.46
1.3
1.4
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
215
1848
1.17
1.46
6.1
7.8
%
1.3
1.3
0.10
215
1835
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
145
1204
1.21
1.45
1.4
1.5
—
—
—
0
0
(3019174) dRVVT (LA screen)
7
28
2.50
1.45
1.3
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
395
3547
1.13
1.45
1.9
1.7
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
15
80
1.88
1.44
1.0
1.2
%
120.3
115.0
0.25
15
74
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
15
80
1.88
1.44
1.0
1.3
%
106.3
93.3
—
8
41
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
144
1196
1.21
1.44
2.1
2.1
g/l
3.0
3.2
1.09
108
910
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
11
52
2.12
1.44
1.1
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
111
897
1.24
1.44
2.3
2.1
nmol/l
12.0
12.2
0.11
99
794
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
35
236
1.49
1.44
1.3
1.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
214
1842
1.17
1.44
6.2
7.9
%
0.7
0.7
0.09
214
1830
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
59
438
1.35
1.44
1.3
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
395
3549
1.13
1.44
1.9
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
265
2319
1.15
1.44
2.5
2.9
e9/l
3.8
4.0
1.05
204
1776
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
140
1160
1.21
1.43
1.8
1.7
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
6
22
2.73
1.43
1.0
1.0
mmol/l
8.5
8.2
—
6
22
(4146454)
49
353
1.39
1.43
2.2
2.7
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
9
39
2.31
1.43
1.1
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
46
329
1.40
1.40
1.1
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
275
2419
1.15
1.39
5.5
6.0
mmol/l
9.4
9.1
0.32
260
2289
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
177
0.51
1.39
1.7
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
134
1110
1.21
1.39
2.7
3.1
g/l
0.2
0.3
0.20
55
392
(3004616) Nuclear Ab [Presence] in Serum
53
390
1.36
1.37
1.3
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
150
1258
1.20
1.37
1.9
1.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
16
89
1.80
1.37
1.2
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
157
1323
1.19
1.36
4.1
5.0
%
1.7
1.6
0.77
146
1232
(44806420)
15
82
1.83
1.35
2.1
2.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
32
215
1.49
1.35
1.1
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
81
636
1.28
1.35
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
81
636
1.28
1.35
1.2
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
58
435
1.34
1.34
2.0
2.1
mg/l
26.8
24.1
0.13
19
115
(3019225) pH of Specimen
396
3577
1.12
1.33
3.9
4.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
58
438
1.33
1.29
1.3
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
90
721
1.25
1.29
2.1
2.1
u/l
6519.8
4004.5
0.29
32
306
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
98
793
1.24
1.28
2.9
2.3
g/l
3.6
3.6
0.12
92
754
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
58
439
1.33
1.27
1.3
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
289
2569
1.13
1.27
1.4
1.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
106
868
1.23
1.25
2.3
2.0
%
94.2
93.4
0.15
100
797
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
61
467
1.31
1.24
1.1
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
58
441
1.32
1.24
1.3
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
39
278
1.41
1.24
1.5
2.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
20
123
1.63
1.23
1.9
2.5
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
87
699
1.25
1.23
3.9
3.5
kpa
8.7
8.6
0.18
87
685
(3051387) C reactive protein [Mass/volume] in Capillary blood
56
731
0.76
1.22
3.8
3.5
mg/l
23.3
24.8
0.09
34
440
(3012501) Base excess in Blood by calculation
86
691
1.25
1.21
3.9
3.5
mmol/l
2.7
2.7
0.01
66
488
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
32
221
1.45
1.21
1.1
1.3
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
86
693
1.25
1.19
3.9
3.5
kpa
5.1
5.0
0.09
86
679
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
15
86
1.75
1.18
1.6
1.4
%
25.4
37.0
—
9
59
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
370
3355
1.11
1.18
4.0
4.1
u/l
236.3
247.2
0.99
343
3152
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
19
117
1.63
1.18
1.5
1.5
pmol/l
14.3
14.8
0.15
19
95
(3044290) Cell count panel - Cerebral spinal fluid
79
632
1.26
1.17
1.3
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
348
3149
1.12
1.16
2.4
2.2
u/l
30.7
53.2
0.84
280
2666
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
56
429
1.31
1.16
1.1
1.1
u/ml
1.3
3.7
2.22
26
177
(3000093) Morphology [Interpretation] in Blood Narrative
36
257
1.40
1.15
1.1
1.1
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
76
607
1.26
1.14
1.4
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
69
545
1.27
1.14
1.4
1.3
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
8
152
0.53
1.14
9.3
12.6
nmol/l
1011.5
825.9
—
8
145
(3007930) Methemoglobin/Hemoglobin.total in Blood
153
1312
1.17
1.13
4.5
5.0
%
0.9
0.9
0.31
142
1221
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
17
103
1.65
1.12
1.4
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
13
221
0.59
1.12
1.6
1.5
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
54
414
1.31
1.12
2.2
1.7
%
89.2
89.8
0.24
54
408
(3017817) Protein [Mass] in Urine collected for unspecified duration
32
225
1.43
1.12
2.6
2.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
60
467
1.29
1.11
1.7
1.4
mu/l
55.4
47.7
0.18
52
409
(3010421) pH of Blood
100
827
1.21
1.10
3.8
3.4
ph
7.4
7.4
0.21
86
677
(3036489) Thrombin time
128
1084
1.19
1.10
2.0
1.9
s
22.4
21.1
0.88
112
937
(3020393) Adenovirus Ag [Presence] in Stool
7
31
2.26
1.10
1.3
1.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
69
548
1.26
1.10
1.3
1.4
u/l
13.0
14.3
0.30
54
453
(3020874) Milk IgE Ab [Units/volume] in Serum
24
160
1.50
1.09
1.0
1.1
u/ml
0.2
2.0
—
6
54
(3028717) Thiamine [Mass/volume] in Blood
7
32
2.19
1.08
1.4
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
29
202
1.44
1.07
1.9
1.8
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
59
1.87
1.07
1.3
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
61
479
1.28
1.07
1.7
1.5
g/l
0.7
0.7
0.13
50
355
(3006576) Bicarbonate [Moles/volume] in Blood
13
74
1.76
1.06
8.0
4.7
mmol/l
24.3
25.5
0.41
13
67
(3001686) Cold agglutinin [Titer] in Serum or Plasma
10
52
1.93
1.06
1.1
1.3
—
132.4
—
0
10
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
23
153
1.51
1.06
1.2
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
112
943
1.19
1.04
2.0
2.0
ug/l
161.4
560.7
3.01
102
877
(3013005) Retinol [Moles/volume] in Serum or Plasma
20
130
1.54
1.02
1.2
1.5
umol/l
2.1
2.0
0.08
20
121
(3003888) Timothy IgE Ab [Units/volume] in Serum
57
447
1.28
1.02
1.1
1.1
u/ml
4.3
4.4
0.02
33
215
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
147
1270
1.16
1.02
2.1
2.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
14
83
1.69
1.01
1.5
1.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
147
1271
1.16
1.01
2.1
2.0
g/l
7.4
7.6
1.23
113
936
(3023183) Ammonium ion [Moles/volume] in Plasma
67
537
1.25
1.01
2.7
2.8
umol/l
29.8
33.1
0.87
60
458
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
158
1374
1.16
1.00
2.2
2.5
%
0.7
0.6
0.63
152
1313
(3009871) Measles virus Ab [Titer] in Serum
15
91
1.65
1.00
1.7
1.7
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
9
48
1.88
1.00
1.6
1.7
mmol/l
3.1
2.7
—
9
40
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
109
0.46
1.00
1.4
1.7
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
44
335
1.32
0.98
4.2
4.0
mmol/l
7.6
7.2
0.43
31
282
(3035320) C reactive protein [Mass/volume] in Body fluid
34
249
1.37
0.97
2.6
2.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
7
36
1.95
0.97
1.0
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
7
36
1.95
0.97
1.0
1.3
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
112
951
1.18
0.97
1.8
2.1
g/l
0.0
0.0
0.78
106
864
(3024354) Oxygen [Partial pressure] in Venous blood
252
2268
1.12
0.96
2.4
2.8
kpa
4.4
4.5
0.20
244
2189
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
18
116
1.55
0.96
1.5
2.0
%
122.1
137.2
0.52
18
110
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
59
469
1.26
0.96
1.2
1.3
nmol/l
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
66
532
1.24
0.96
1.3
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
146
1269
1.16
0.95
1.4
1.4
iu/l
32.5
34.7
0.31
120
1105
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
97
815
1.20
0.94
1.5
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
16
101
1.59
0.93
1.3
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
41
312
1.32
0.93
1.3
1.2
—
—
—
0
0
(4094501)
103
872
1.19
0.93
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
61
490
1.25
0.92
1.1
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
37
278
1.33
0.91
1.5
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
62
500
1.24
0.91
1.4
1.2
u/ml
324.5
262.4
0.86
33
299
(3033923) Metanephrine [Moles/time] in 24 hour Urine
14
86
1.63
0.90
1.0
1.1
umol/24h
0.6
0.7
—
8
44
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
21
143
1.47
0.89
1.2
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
21
143
1.47
0.89
1.2
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
21
143
1.47
0.89
1.2
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
21
143
1.47
0.89
1.2
1.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
145
1268
1.15
0.88
2.1
2.0
g/l
3.7
3.8
0.41
105
887
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
65
529
1.23
0.88
7.3
4.3
iu/ml
3297.1
380.7
0.52
16
60
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
9
155
0.58
0.88
12.8
18.0
nmol/l
1517.8
1505.9
—
9
149
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
13
79
1.65
0.88
1.2
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
8
44
1.82
0.85
1.0
1.1
umol/24h
1.2
1.7
—
8
44
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
8
44
1.82
0.85
2.8
2.9
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
18
120
1.50
0.85
1.8
1.7
umol/l
241.9
159.9
—
8
62
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
25
179
1.40
0.84
1.3
1.1
u/l
1.2
1.1
—
9
92
(3021447) Carbon dioxide [Partial pressure] in Venous blood
297
2725
1.10
0.82
2.9
3.3
kpa
5.8
5.8
0.03
289
2644
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
32
1.88
0.81
1.0
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
60
490
1.23
0.81
1.1
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
8
47
1.70
0.80
1.4
2.1
umol/l
12.4
19.2
—
8
47
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
18
122
1.48
0.80
1.0
1.1
miu/ml
1328.3
1596.8
0.88
18
122
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
28
207
1.36
0.79
1.0
1.1
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
25
0.00
0.79
0.0
4.9
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
11
66
1.67
0.78
1.3
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
60
492
1.22
0.78
1.5
1.3
u/ml
108.6
110.8
0.05
12
98
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
12
74
1.62
0.78
1.0
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
210
1899
1.11
0.78
1.7
1.6
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
39
305
1.28
0.76
1.5
1.4
e6/l
7649.7
107725.9
1.62
23
205
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
34
1.77
0.76
4.7
12.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
178
1599
1.12
0.75
2.8
2.8
ug/l
0.7
0.7
0.04
123
945
(3000034) Microalbumin [Mass/volume] in Urine
39
306
1.28
0.75
3.8
2.7
mg/l
23.2
20.1
0.09
25
210
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
9
54
1.67
0.74
1.3
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
30
227
1.32
0.74
1.5
1.5
umol/l
10.3
11.5
0.67
30
218
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
50
405
1.24
0.74
1.1
1.3
mmol/l
6.9
7.5
0.77
31
286
(3029396) Erythrocyte agglutination [Presence] in Blood
7
39
1.80
0.72
2.6
3.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
53
434
1.22
0.72
1.3
1.2
u/ml
5.3
4.5
0.15
26
171
(1761482) Bacteria [#/volume] in Urine by Culture
98
849
1.16
0.72
5.1
4.7
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
7
40
1.75
0.71
2.6
3.0
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
5
26
1.92
0.70
1.4
2.2
—
36.5
—
0
7
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
38
300
1.27
0.70
1.6
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
39
309
1.26
0.70
1.2
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
305
2826
1.09
0.70
3.1
3.2
ng/l
81.5
81.6
0.01
267
2349
(43055442) Apixaban [Mass/volume] in Serum or Plasma
7
41
1.71
0.70
1.0
1.5
ug/l
135.6
116.7
—
7
36
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
41
1.71
0.70
1.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
46
564
0.81
0.69
3.1
3.8
u/ml
30.2
47.0
0.80
46
557
(3020491) Glucose [Moles/volume] in Blood
31
239
1.30
0.69
1.4
2.2
mmol/l
6.9
6.7
0.14
20
160
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
28
213
1.32
0.68
1.8
1.8
%
15.0
13.8
0.15
13
82
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
177
1601
1.11
0.68
7.0
8.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
47
383
1.23
0.67
1.1
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
226
2071
1.10
0.67
1.4
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
93
0.54
0.66
1.4
1.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
35
276
1.27
0.66
2.5
3.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
33
259
1.28
0.65
2.4
1.7
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
44
1.59
0.65
1.9
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
292
2712
1.08
0.65
3.0
3.3
mmol/l
2.0
2.1
0.15
240
2234
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
37
295
1.26
0.65
1.4
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
168
1521
1.11
0.64
6.0
8.2
mmol/l
24.6
24.4
0.40
153
1420
(4306422)
53
441
1.20
0.63
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
34
269
1.27
0.63
2.6
2.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
155
1714
0.90
0.63
1.5
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
54
451
1.20
0.62
1.7
1.2
u/l
17.9
30.2
1.92
43
380
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
79
1.52
0.62
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
79
1.52
0.62
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
12
79
1.52
0.62
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
79
1.52
0.62
1.1
1.1
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
28
217
1.29
0.61
1.8
1.8
%
73.2
72.3
0.14
28
207
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
30
1.67
0.61
2.4
2.0
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
14
96
1.46
0.61
1.4
1.3
pmol/l
23.7
50.9
—
5
29
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
234
2160
1.09
0.61
4.0
3.8
%
22.7
21.0
0.84
93
907
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
32
253
1.27
0.61
1.0
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
17
233
0.73
0.60
1.5
1.6
u/l
4.8
5.2
—
6
104
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
13
88
1.48
0.60
1.8
2.2
%
145.2
175.4
0.74
13
82
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
8
51
1.57
0.60
1.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
19
139
1.37
0.60
2.1
2.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1160
11257
1.04
0.59
3.0
2.9
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
18
131
1.38
0.59
8.1
4.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
35
432
0.81
0.58
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
35
432
0.81
0.58
1.1
1.1
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.5
—
14.2
—
0
16
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
52
437
1.19
0.58
1.1
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
15
208
0.72
0.58
1.9
1.5
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
32
255
1.26
0.58
1.2
1.6
ug/l
3.0
4.2
0.45
20
203
(3000285) Sodium [Moles/volume] in Blood
8
54
1.48
0.57
1.0
1.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
21
158
1.33
0.57
1.1
1.6
nmol/l
5.6
5.6
0.00
14
129
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
98
868
1.13
0.56
1.5
2.1
g/l
0.0
0.0
0.00
92
799
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
32
256
1.25
0.56
1.4
1.2
—
—
—
0
0
(4268621)
36
293
1.23
0.55
2.4
2.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
13
90
1.45
0.55
1.5
1.2
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
13
90
1.45
0.55
1.8
1.6
%
28.5
27.5
0.06
13
84
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
69
598
1.16
0.54
1.1
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
20
262
0.76
0.54
1.1
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
45
376
1.20
0.54
1.2
1.1
g/l
1.5
1.5
0.13
40
333
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
30
240
1.25
0.53
1.3
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
30
240
1.25
0.53
1.3
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
30
240
1.25
0.53
1.3
1.5
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
11
74
1.49
0.53
1.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
61
525
1.16
0.53
1.4
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
61
525
1.16
0.53
1.2
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
9
62
1.45
0.53
1.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
91
1.43
0.53
1.0
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
99
883
1.12
0.52
1.5
2.1
g/l
0.0
0.0
0.49
93
801
(3039443) Prostate specific Ag panel - Serum or Plasma
26
205
1.27
0.52
1.6
1.6
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
43
360
1.20
0.51
1.4
1.4
mosm/kgh2o
275.5
276.0
0.06
33
270
(3024932) HLA-DR beta [Type]
9
64
1.41
0.51
1.1
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
51
434
1.18
0.51
1.1
1.1
u/ml
0.5
1.3
0.95
23
179
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
22
170
1.30
0.51
2.5
1.7
u/field
1.2
2.7
0.74
16
120
(3000012) Reticulocyte production index
22
170
1.30
0.51
1.4
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
34
278
1.22
0.51
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
33
269
1.23
0.51
1.4
1.2
—
—
—
0
0
(4211845)
24
188
1.28
0.51
3.0
3.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
65
1.39
0.50
1.3
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
34
279
1.22
0.50
2.5
2.2
u/field
1.8
2.3
0.28
15
108
(3006462) Nitrate [Presence] in Urine
22
171
1.29
0.49
3.1
3.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
130
1183
1.10
0.49
1.9
2.0
g/l
9.5
10.2
1.67
109
972
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
12
84
1.43
0.49
1.5
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
21
268
0.78
0.49
1.2
1.5
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
7
107
0.65
0.48
1.7
2.4
nmol/l
202.0
150.4
—
7
94
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
43
507
0.85
0.48
1.4
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
112
1013
1.11
0.48
1.6
2.0
g/l
38.7
37.7
1.15
97
844
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
21
163
1.29
0.48
1.1
1.1
u/ml
6.9
6.5
—
6
20
(3027456) Digoxin [Moles/volume] in Serum or Plasma
80
710
1.13
0.47
3.5
3.1
nmol/l
0.8
0.8
0.08
70
554
(3000991) Gas panel - Venous blood
260
2442
1.07
0.47
5.5
7.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
90
806
1.12
0.46
1.6
1.6
mu/l
280.2
333.6
1.52
83
722
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
59
514
1.15
0.46
1.6
1.7
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
13
94
1.38
0.46
1.2
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
11
77
1.43
0.45
1.0
2.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
11
77
1.43
0.45
1.3
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
32
265
1.21
0.44
2.0
2.1
e9/l
1.2
1.1
0.24
23
171
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
83
743
1.12
0.44
2.5
2.9
mg/l
1.5
1.5
0.26
73
668
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
17
130
1.31
0.43
1.1
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
20
157
1.28
0.43
1.9
1.4
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
23
184
1.25
0.43
1.0
1.2
u/l
95.5
78.8
0.72
18
136
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
23
184
1.25
0.43
1.0
1.2
u/l
23.9
22.7
0.05
18
133
(3010726) Horse dander IgE Ab [Units/volume] in Serum
47
405
1.16
0.43
1.1
1.1
u/ml
0.8
2.2
—
8
94
(40760888) Immunoglobulin light chains.free panel - Serum
82
735
1.12
0.43
3.4
3.4
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
72
641
1.13
0.42
1.6
1.3
mmol/l
73.3
61.4
1.69
60
515
(3035947) Staphylolysin Ab [Units/volume] in Serum
16
122
1.31
0.42
1.2
1.1
—
3.5
—
0
6
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
21
167
1.26
0.41
1.1
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
13
96
1.36
0.41
1.4
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
33
1.52
0.41
3.6
2.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
11
79
1.39
0.40
1.3
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
51
445
1.15
0.40
1.1
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
34
1.47
0.40
6.2
2.5
u/field
0.2
0.7
—
5
34
(3008116) Ketones [Moles/volume] in Urine by Test strip
8
60
1.33
0.40
1.4
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
35
411
0.85
0.39
4.0
5.3
umol/l
350.0
374.2
0.36
28
359
(3036071) Salmonella sp Ab [Titer] in Serum
13
97
1.34
0.39
1.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
38
325
1.17
0.39
1.1
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
14
106
1.32
0.39
1.0
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
115
1250
0.92
0.39
3.7
3.3
u/ml
318.7
930.9
1.15
97
1046
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
15
115
1.31
0.38
1.3
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
15
115
1.31
0.38
1.3
1.6
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
9
66
1.36
0.38
1.0
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
26
215
1.21
0.38
1.3
1.6
—
—
—
0
0
(3024471) HLA-A [Type]
9
67
1.34
0.38
1.0
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
74
666
1.11
0.37
2.1
1.5
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
8
114
0.70
0.37
1.6
1.5
ug/l
0.3
0.4
—
8
67
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
15
116
1.29
0.37
1.5
1.7
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
59
525
1.13
0.36
1.1
1.1
u/ml
1.6
1.3
0.13
25
200
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
12
90
1.33
0.35
1.3
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
106
977
1.09
0.35
2.8
2.8
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
20
244
0.82
0.34
1.5
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
22
181
1.22
0.34
1.2
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
44
1.36
0.34
1.2
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
38
436
0.87
0.34
1.4
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
46
1.30
0.33
1.5
1.9
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
107
990
1.08
0.33
5.8
6.2
mmol/l
1.2
1.2
0.21
90
865
(3005033) Fetal Nuchal fold Thickness US
40
350
1.14
0.32
1.5
1.4
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
56
502
1.12
0.32
1.1
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
20
241
0.83
0.31
1.4
1.5
g/l
1.1
1.0
0.68
20
241
(3047352) Trisomy 18 risk [Likelihood] in Fetus
40
352
1.14
0.31
1.5
1.4
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
53
1.32
0.30
1.3
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
37
324
1.14
0.30
1.1
1.1
u/ml
1.4
2.9
1.01
16
128
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
63
693
0.91
0.30
2.2
2.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
45
401
1.12
0.29
1.2
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
42
373
1.13
0.29
3.6
3.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
33
288
1.15
0.29
2.3
3.1
%
59.7
57.3
0.31
27
189
(3002619) Bacteria identified in Specimen by Culture
7
57
1.23
0.29
1.1
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
41
364
1.13
0.28
1.8
2.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
13
103
1.26
0.28
1.3
1.2
g/l
34.6
39.3
—
5
49
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
138
1300
1.06
0.28
1.6
1.7
g/l
1.7
1.6
0.51
109
1113
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
10
76
1.32
0.28
1.0
1.1
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
8
62
1.29
0.28
2.5
1.3
%
17.6
22.3
—
8
55
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
34
386
0.88
0.28
1.1
1.2
u/l
55.2
58.0
0.15
24
263
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
43
384
1.12
0.27
1.0
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
8
65
1.23
0.27
1.4
1.2
umol/l
20.5
17.3
—
8
57
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
11
139
0.79
0.26
1.6
3.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
11
139
0.79
0.26
1.3
1.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
25
215
1.16
0.26
2.4
2.2
ml
675.6
618.4
0.26
18
146
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
67
1.19
0.26
1.1
1.4
ng/l
91.3
97.5
—
8
67
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
95
886
1.07
0.26
2.7
3.0
u/ml
0.4
0.4
0.33
48
497
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
71
0.70
0.26
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
54
491
1.10
0.26
1.5
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
17
203
0.84
0.25
5.4
3.3
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
9
72
1.25
0.25
2.2
1.1
mmol/l
3.1
3.2
—
9
65
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
75
694
1.08
0.25
1.8
1.7
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
9
73
1.23
0.25
1.2
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
132
1396
0.94
0.25
3.0
3.6
mmol/l
24.2
24.4
0.40
115
1251
(3044242) Glucose [Moles/volume] in Arterial blood
18
151
1.19
0.25
2.1
2.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
107
1005
1.07
0.25
3.1
3.2
mg/l
32.5
114.4
0.83
85
821
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
76
1.18
0.24
1.2
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
43
388
1.11
0.24
1.6
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
51
465
1.10
0.24
1.5
1.5
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
14
169
0.83
0.24
1.9
1.2
u/l
8.7
9.9
0.62
14
150
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
90
842
1.07
0.23
1.3
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
18
152
1.19
0.23
1.1
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
38
1.32
0.23
1.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
38
1.32
0.23
1.0
1.0
—
—
—
0
0
(44806118)
35
313
1.12
0.23
1.5
1.3
—
—
—
0
0
(44790047)
35
313
1.12
0.23
1.5
1.3
—
—
—
0
0
(44790048)
35
313
1.12
0.23
1.5
1.3
—
—
—
0
0
(44790049)
35
313
1.12
0.23
1.5
1.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
34
379
0.90
0.22
1.4
1.4
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
40
1.25
0.22
1.4
1.3
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
13
157
0.83
0.22
16.1
11.3
mmol/l
0.6
0.6
0.21
13
141
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
47
429
1.10
0.22
1.4
1.4
—
—
—
0
0
(44806071)
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
1.7
—
0
11
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
19
220
0.86
0.21
1.2
1.2
u/l
12.2
19.1
1.15
14
184
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
47
430
1.09
0.21
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
47
430
1.09
0.21
1.4
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
186
1786
1.04
0.21
4.9
6.4
mmol/l
25.2
25.1
0.14
186
1771
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
40
363
1.10
0.21
1.5
1.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
12
98
1.23
0.21
2.4
2.7
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
25
220
1.14
0.21
1.0
1.0
ng/l
899.4
732.1
0.90
15
145
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
106
1003
1.06
0.21
3.2
3.2
mg/l
29.4
42.1
1.03
84
816
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.5
—
338.8
—
0
13
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
11
89
1.24
0.21
3.0
3.2
mg/l
12.3
7.3
—
6
72
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
47
431
1.09
0.20
1.4
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
76
712
1.07
0.20
2.9
3.2
u/ml
82.2
870.7
1.38
68
649
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
2795.6
—
0
8
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
30
334
0.90
0.20
2.6
3.8
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
44
403
1.09
0.20
1.5
1.4
nmol/l
0.2
0.3
1.81
34
292
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
396
0.91
0.19
1.4
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
17
146
1.17
0.19
1.1
1.2
nmol/l
139.2
130.4
0.35
17
146
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
29
322
0.90
0.18
1.4
1.9
ug/l
21.3
21.5
0.01
29
317
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
13
109
1.19
0.18
1.2
1.1
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
19
217
0.87
0.18
1.7
1.3
u/l
330.8
309.7
0.08
19
208
(4027681)
20
175
1.14
0.18
1.3
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
15
128
1.17
0.18
1.7
2.0
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
15
128
1.17
0.18
1.1
1.4
umol/l
3.1
3.8
0.48
15
114
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
15
128
1.17
0.18
1.2
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
239
2465
0.97
0.18
1.3
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
22
248
0.89
0.18
5.3
6.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
25
223
1.12
0.18
1.0
1.0
ng/l
42.2
45.4
0.09
13
149
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
102
971
1.05
0.17
3.2
3.1
ratio
1.1
1.5
1.15
11
87
(3035880) pH of Pleural fluid
16
138
1.16
0.17
1.8
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
16
138
1.16
0.17
2.6
2.5
%
35.3
42.2
—
7
45
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
184
0.87
0.17
1.5
1.5
—
—
—
0
0
(3039000) Anion gap in Blood
76
718
1.06
0.17
6.7
7.0
mmol/l
11.0
10.9
0.10
68
638
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
375
3836
0.98
0.17
3.5
3.9
ug/l
5.7
25.4
2.61
290
3075
(3051101) Glucose [Moles/volume] in Cord blood
7
63
1.11
0.17
3.7
6.6
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
66
0.76
0.17
1.0
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
51
475
1.07
0.17
2.2
3.3
%
1.5
1.4
0.06
44
373
(3023511) Choriogonadotropin [Units/volume] in Urine
36
392
0.92
0.16
1.1
1.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
68
1.18
0.16
1.1
1.1
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
76
719
1.06
0.16
6.7
7.0
mmol/l
104.7
105.0
0.23
68
639
(3045788) Cell count panel - Pleural fluid
22
246
0.89
0.16
1.8
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
70
1.14
0.16
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
33
302
1.09
0.16
4.7
3.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
80
0.75
0.15
1.0
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
73
692
1.06
0.15
1.4
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
16
140
1.14
0.15
1.2
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
26
236
1.10
0.14
1.3
1.3
mmol/l
12.1
12.0
—
9
55
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
38
352
1.08
0.14
5.5
6.0
mg/l
11.5
11.9
0.23
33
326
(3014133) Dog dander IgE Ab [Units/volume] in Serum
38
352
1.08
0.14
1.1
1.1
u/ml
2.7
2.9
0.05
11
129
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
89
0.79
0.14
1.4
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
44
411
1.07
0.14
4.2
2.9
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
31
285
1.09
0.14
1.1
1.0
u/ml
0.2
0.3
—
8
70
(3033705) Calcium.ionized [Moles/volume] in Venous blood
36
388
0.93
0.14
2.3
2.2
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
24
218
1.10
0.13
1.0
1.0
ng/l
314.4
340.3
0.14
14
148
(3024891) Influenza virus A+B Ag [Presence] in Specimen
82
784
1.05
0.13
1.1
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
32
296
1.08
0.13
1.2
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
29
314
0.92
0.12
1.6
1.4
e6/l
1393.6
2370.5
1.04
22
231
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
42
395
1.06
0.12
1.4
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
18
162
1.11
0.11
1.5
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
53
503
1.05
0.11
1.5
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
33
353
0.93
0.11
1.7
1.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
14
157
0.89
0.11
1.3
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
23
250
0.92
0.11
1.2
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
96
927
1.04
0.11
1.8
1.8
iu/l
5.0
4.4
0.28
37
330
(3019897) Erythrocyte distribution width [Ratio] by Automated count
36
383
0.94
0.10
2.4
2.8
%
13.4
13.2
0.40
36
377
(3042733) HLA Ab [Presence] in Serum
6
54
1.11
0.09
5.3
5.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
15
165
0.91
0.08
1.5
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
18
165
1.09
0.08
1.2
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
18
165
1.09
0.08
2.1
2.4
e6/l
388.4
691.4
—
7
67
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
15
136
1.10
0.08
1.1
1.6
mmol/l
9.0
8.2
—
8
80
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
58
1.03
0.08
1.2
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
60
0.83
0.08
1.6
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
45
430
1.05
0.08
1.1
1.1
iu/ml
19.7
1837.4
—
7
92
(4015189)
10
88
1.14
0.08
1.5
2.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
52
500
1.04
0.07
2.1
1.6
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
15
137
1.10
0.07
1.1
1.1
%
102.1
94.4
0.39
15
101
(4281824)
54
520
1.04
0.07
1.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
77
1.04
0.07
1.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
81
0.86
0.07
1.3
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
98
956
1.03
0.07
2.0
1.8
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
9
88
1.02
0.07
1.2
1.9
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
100
0.90
0.06
1.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
24
254
0.94
0.06
1.3
1.3
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
17
158
1.08
0.06
1.9
1.5
u/l
13.2
13.0
0.03
17
150
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
15
162
0.93
0.06
1.5
1.5
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
37
355
1.04
0.06
1.5
1.4
g/l
31.6
32.5
0.16
37
319
(3047189) Immunofixation for 24 hour Urine
12
131
0.92
0.05
2.3
1.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
15
160
0.94
0.04
1.3
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
46
447
1.03
0.04
1.3
1.2
u/ml
1.1
4.2
2.52
13
131
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
37
358
1.03
0.04
3.2
4.7
u/ml
524.1
58.0
—
9
103
(3010503) CD19 cells [#/volume] in Blood
19
180
1.06
0.04
2.1
2.4
e9/l
0.1
0.4
0.84
19
173
(3014271) Vancomycin [Susceptibility]
19
180
1.06
0.04
3.5
2.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
25
240
1.04
0.03
2.0
2.0
%
10.5
10.8
0.17
25
240
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
112
1134
0.99
0.03
2.3
1.7
mg/l
4.3
3.8
0.12
84
822
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
14
148
0.95
0.02
2.6
2.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
19
182
1.04
0.02
1.2
1.1
ratio
1.0
1.1
—
7
61
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
69
680
1.01
0.02
1.5
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
95
940
1.01
0.02
1.3
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
12
113
1.06
0.01
1.8
1.9
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
17
177
0.96
0.01
1.2
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
18
187
0.96
0.01
1.1
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
162
1629
0.99
0.01
1.9
1.8
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
18
186
0.97
0.00
1.1
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
14
142
0.99
0.00
1.6
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
14
142
0.99
0.00
1.6
1.7
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
15
148
1.01
0.00
1.1
1.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
24
238
1.01
0.00
1.2
1.2
u/ml
0.1
1.0
1.23
13
105
(3028308) Erythrocytes [#/volume] in Pleural fluid
27
275
0.98
0.00
1.6
1.4
e6/l
271453.1
45761.3
0.50
16
153
(3023419) Bacteria identified in Sputum by Culture
38
385
0.99
0.00
2.3
2.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
40
405
0.99
0.00
1.5
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
59
595
0.99
0.00
3.2
2.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
12
121
0.99
0.00
1.0
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
34
341
1.00
0.00
1.1
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
15
146
1.03
0.00
6.8
11.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
15
146
1.03
0.00
1.0
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
56
563
0.99
0.00
1.2
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
10
97
1.03
0.00
1.2
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
25
247
1.01
0.00
1.1
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
20
203
0.99
0.00
1.1
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
52
0.96
0.00
26.2
8.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
89
0.90
0.00
1.4
1.1
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
9
0.00
0.00
0.0
4.7
—
372.6
—
0
9
(3009677) Dengue virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
84
0.95
0.00
8.6
2.3
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
33
330
1.00
0.00
1.5
1.5
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.7
—
15.0
—
0
7
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
72
0.97
0.00
2.7
3.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
54
0.93
0.00
1.2
1.6
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.1
—
0
5
(4133840)
6
66
0.91
0.00
1.0
1.1
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
49
1.02
0.00
1.8
2.1
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
1308.0
—
0
5
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
0.2
—
0
6
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043722) Hyaline casts [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
1.0
—
1.0
—
0
6
(3041918) Cholesterol [Moles/volume] in Pleural fluid
5
54
0.93
0.00
3.2
1.2
mmol/l
1.1
1.9
—
5
30
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
17
170
1.00
0.00
1.0
1.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
59
0.85
0.00
26.2
7.8
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
1.5
—
0
7
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
53
0.94
0.00
2.2
1.2
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
124.4
—
0
6
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
71
0.99
0.00
2.7
2.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
69
0.87
0.00
1.2
2.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
2.3
—
0
8
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
3.0
—
0
5
(3036180) Methadone [Presence] in Urine
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
84
0.95
0.00
8.6
2.3
—
—
—
0
0
(4198724)
9
90
1.00
0.00
1.1
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_LICHENSCLERATROPH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_LICHENSCLERATROPH | 0.833 [0.75, 0.92] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 1814 out of 13288 females with L12_LICHENSCLERATROPH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_LICHENSCLERATROPH | 0.786 [0.64, 0.97] | 0.023 |
| Birth year | 0.992 [0.98, 1.0] | 0.134 |
During the follow-up period (1.1.1998 — 31.12.2019), 145 out of 2735 males with L12_LICHENSCLERATROPH died.
Mortality risk
Mortality risk for people of age
years, who have L12_LICHENSCLERATROPH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.087% | 0.13% |
| 5 | 0.44% | 0.996% |
| 10 | 0.985% | 2.672% |
| 15 | 1.926% | 5.039% |
| 20 | 3.252% | 8.678% |
Relationships between endpoints
↥Index endpoint: L12_LICHENSCLERATROPH – Lichen sclerosus et atrophicus
GWS hits: 4
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data